Here, we describe the epidemiology of RSV, the RSV virion structure, key neutralizing epitopes on the pre- and post-fusion forms of the fusion protein and implications for vaccine development.

AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. The antibody ...

Among the pathogens most closely monitored for their public health impact are respiratory syncytial virus (RSV), influenza viruses, pneumococcal bacteria and SARS-CoV-2. Pneumonia does not ...

In the study, "Phollow reveals in situ phage transmission dynamics in the zebrafish gut microbiome at single-virion resolution," published in Nature Microbiology, researchers designed a live ...

GSK has reported new clinical data pointing to a benefit with its respiratory syncytial virus (RSV) vaccine Arexvy when used to treat a younger age group than the over-60s for whom it is approved.

The corps is a holistic structure. And let’s not even talk about the ‘attached’ units that break brigades into battalions and, let’s be honest, are not valued as much as the ‘main’ ones. It is time to ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

Apr. 22, 2025 — Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million ...

A new study to boost the number of expectant mothers having the Respiratory Syncytial Virus (RSV) immunisation and investigate the impact of RSV infections in pregnancy has received backing from the ...

Kennedy Jr., a longtime anti-vaccine activist. HealthDay News — A panel of federal health experts recommended expanded vaccine options for several diseases, including respiratory syncytial virus (RSV) ...